Physician profile
Jahnavi Sagi
NPI 1982012621
$369.97
in general payments reported to CMS, 2019-2025
7 companies · $76.78 in 2025
The $76.78 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.66 · 2020: $13.92 · 2021: $69.62 · 2022: $34.89 · 2023: $19.59 · 2024: $141 · 2025: $76.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $125.42 | 2021-2024 | |
| Pfizer INC. | $77.22 | 2019-2025 | |
| Amgen INC. | $61.82 | 2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $38.83 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.44 | 2024 | Xifaxan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.58 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.66 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jahnavi Sagi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.